2446 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 49 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
AADACArylacetamide deacetylaseEnzymes
Predicted intracellular proteins
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Tissue enrichedGroup enriched
ABCA12ATP binding cassette subfamily A member 12Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoli
Vesicles
Plasma membrane
Cytosol
MixedGroup enriched
ABCA13ATP binding cassette subfamily A member 13Predicted membrane proteins
Vesicles
Centrosome
Cytosol
MixedTissue enriched
ABCA4ATP binding cassette subfamily A member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Lung cancer: 2.45e-4
Urothelial cancer: 2.72e-4
Tissue enhancedTissue enhanced
ABCB9ATP binding cassette subfamily B member 9Predicted intracellular proteins
Predicted membrane proteins
Transporters
VesiclesGlioma: 4.62e-4
MixedTissue enhanced
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
MixedMixed
ABCC4ATP binding cassette subfamily C member 4Plasma proteins
Predicted membrane proteins
Transporters
Renal cancer: 2.25e-10
Endometrial cancer: 9.89e-4
Tissue enrichedTissue enhanced
ABCC9ATP binding cassette subfamily C member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
MixedMixed
ABCG2ATP binding cassette subfamily G member 2 (Junior blood group)Cancer-related genes
CD markers
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
MixedTissue enhanced
ABI3BPABI family member 3 binding proteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 6.14e-4
MixedMixed
ABLIM2Actin binding LIM protein family member 2Predicted intracellular proteins
Nucleoplasm
Mitochondria
MixedTissue enhanced
ABLIM3Actin binding LIM protein family member 3Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cell Junctions
Renal cancer: 1.28e-4
MixedTissue enhanced
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
AC006116.20Predicted secreted proteins
MixedTissue enriched
AC113404.1Ras-related protein Rap-1b-like protein Predicted intracellular proteins
MixedTissue enriched
AC131097.4Predicted intracellular proteins
Tissue enhancedTissue enhanced
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Renal cancer: 2.12e-5
Liver cancer: 4.21e-4
Tissue enhancedGroup enriched
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Tissue enhancedGroup enriched
ACHEAcetylcholinesterase (Cartwright blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Renal cancer: 3.88e-5
Glioma: 7.16e-4
MixedTissue enhanced
ACKR2Atypical chemokine receptor 2G-protein coupled receptors
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
MixedTissue enhanced
ACKR4Atypical chemokine receptor 4G-protein coupled receptors
Predicted membrane proteins
Vesicles
Mitochondria
MixedMixed
ACOT11Acyl-CoA thioesterase 11Predicted intracellular proteins
CytosolRenal cancer: 3.07e-8
Colorectal cancer: 9.37e-4
MixedMixed
ACPPAcid phosphatase, prostateCancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enrichedTissue enriched
ACTL10Actin like 10Predicted secreted proteins
MixedTissue enriched
ACTL8Actin like 8Predicted intracellular proteins
CytosolEndometrial cancer: 1.62e-6
Head and neck cancer: 7.02e-4
MixedTissue enriched
ACTRT3Actin related protein T3Predicted intracellular proteins
NucleoplasmEndometrial cancer: 4.11e-4
MixedTissue enriched
ACVR1CActivin A receptor type 1CEnzymes
Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
ACY3Aminoacylase 3Enzymes
Predicted intracellular proteins
Endometrial cancer: 4.80e-4
MixedTissue enhanced
ADAM12ADAM metallopeptidase domain 12Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membraneRenal cancer: 2.39e-14
MixedTissue enriched
ADAM23ADAM metallopeptidase domain 23Predicted intracellular proteins
Predicted membrane proteins
MixedGroup enriched
ADAM28ADAM metallopeptidase domain 28Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Plasma membrane
Mitochondria
Endometrial cancer: 3.17e-4
MixedTissue enhanced
ADAM33ADAM metallopeptidase domain 33Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Nuclear speckles
Plasma membrane
MixedMixed
ADAMTS12ADAM metallopeptidase with thrombospondin type 1 motif 12Plasma proteins
Predicted secreted proteins
Nucleoli
Mitochondria
Urothelial cancer: 6.78e-4
MixedMixed
ADAMTS14ADAM metallopeptidase with thrombospondin type 1 motif 14Cancer-related genes
Plasma proteins
Predicted secreted proteins
CytosolMixedTissue enhanced
ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15Predicted secreted proteins
CytosolUrothelial cancer: 5.63e-5
Glioma: 9.00e-4
Lung cancer: 9.72e-4
MixedTissue enhanced
ADAMTS17ADAM metallopeptidase with thrombospondin type 1 motif 17Disease related genes
Predicted intracellular proteins
Predicted secreted proteins
NucleusMixedMixed
ADAMTS5ADAM metallopeptidase with thrombospondin type 1 motif 5Cancer-related genes
Predicted secreted proteins
NucleoplasmRenal cancer: 2.46e-4
Thyroid cancer: 8.54e-4
MixedTissue enhanced
ADAMTS7ADAM metallopeptidase with thrombospondin type 1 motif 7Plasma proteins
Predicted secreted proteins
VesiclesStomach cancer: 9.53e-4
MixedTissue enhanced
ADAMTSL5ADAMTS like 5Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatusMixedTissue enhanced
ADCY5Adenylate cyclase 5Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Intermediate filamentsRenal cancer: 7.46e-6
MixedTissue enhanced
ADCY7Adenylate cyclase 7Enzymes
Predicted intracellular proteins
Predicted membrane proteins
CytosolCervical cancer: 5.31e-4
MixedMixed
ADD2Adducin 2Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol
Tissue enhancedGroup enriched
ADGRB1Adhesion G protein-coupled receptor B1Cancer-related genes
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhancedTissue enriched
ADGRB2Adhesion G protein-coupled receptor B2G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
CentrosomeLung cancer: 4.02e-5
Breast cancer: 6.46e-4
Tissue enhancedTissue enriched
ADGRE1Adhesion G protein-coupled receptor E1G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
MixedTissue enhanced
ADGRE2Adhesion G protein-coupled receptor E2CD markers
G-protein coupled receptors
Predicted membrane proteins
VesiclesRenal cancer: 4.35e-6
MixedTissue enhanced
ADGRF1Adhesion G protein-coupled receptor F1G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 1.35e-5
MixedTissue enhanced
ADGRF4Adhesion G protein-coupled receptor F4G-protein coupled receptors
Predicted membrane proteins
MitochondriaPancreatic cancer: 5.52e-4
MixedGroup enriched
ADGRG3Adhesion G protein-coupled receptor G3G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
MixedGroup enriched
ADGRG5Adhesion G protein-coupled receptor G5G-protein coupled receptors
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Nuclear membrane
Vesicles
Cervical cancer: 4.25e-4
MixedTissue enhanced
Page of 49 | next »